# Effect of Melatonin and Metformin on Glycemic Control Genotoxicity and Cytotoxicity Markers in Patients With Prediabetes

> **NCT03848533** · PHASE2 · UNKNOWN · sponsor: **University of Guadalajara** · enrollment: 42 (estimated)

## Conditions studied

- PreDiabetes

## Interventions

- **DRUG:** melatonin
- **DRUG:** metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03848533
- **Lead sponsor:** University of Guadalajara
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-22
- **Primary completion:** 2021-08
- **Final completion:** 2021-12
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2019-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03848533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03848533, "Effect of Melatonin and Metformin on Glycemic Control Genotoxicity and Cytotoxicity Markers in Patients With Prediabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03848533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*